article thumbnail

Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease

Cardiovascular Diabetology

Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Information on GLD (dispended 6 months before or after coronary angiography) was collected from the Swedish Prescribed Drug Registry.

article thumbnail

Anthos Presents New Analysis from P2 AZALEA-TIMI 71 Study

DAIC

4] "Many patients taking antiplatelet therapy are simply not prescribed anticoagulants because of the fear of bleeding, leaving them without protection from the risk of stroke,” said Dan Bloomfield, MD, chief medical officer of Anthos Therapeutics. incidence rate for rivaroxaban to a 3.5% incidence rate for abelacimab 150 mg). [1] vs 4.6%).

article thumbnail

New 'atherosclerosis atlas' sheds light on heart attacks, strokes

Medical Xpress - Cardiology

University of Virginia School of Medicine researchers have created an "atlas of atherosclerosis" that reveals, at the level of individual cells, critical processes responsible for forming the harmful plaque buildup that causes heart attacks, strokes, and coronary artery disease.

article thumbnail

Atrial Fibrillation and Stable Coronary Artery Disease

The New England Journal of Medicine

Patients with atrial fibrillation are at high risk for stroke, and international guidelines recommend oral anticoagulant therapy. In patients with stable vascular disease without atrial fibrillation, antiplatelet therapy is recommended. When patients with both conditions present with.

article thumbnail

Colchicine for symptomatic coronary artery disease after percutaneous coronary intervention

Open Heart

We aimed to perform a systematic review and meta-analysis to study the effects of colchicine in patients with symptomatic coronary artery disease (CAD) who have undergone PCI. These results were driven mainly by the reduction in repeat vessel revascularisation, stroke and stent thrombosis.

article thumbnail

Investigating the impact of multidimensional sleep traits on cardiovascular diseases and the mediating role of depression

Open Heart

to 1.45) for insomnia on stroke to 1.55 (95% CI 1.28 to 1.45) for insomnia on stroke to 1.55 (95% CI 1.28 MDD also partially mediated the causal effects of insomnia on stroke, sleep duration on CAD, MI and HF, daytime napping on HF and daytime sleepiness on CAD. to 1.89) for insomnia on MI. to 1.89) for insomnia on MI.

article thumbnail

Propensity score-based comparison of high-risk coronary artery bypass grafting vs. left ventricular assist device implantation in patients with coronary artery disease and advanced heart failure

Frontiers in Cardiovascular Medicine

ObjectivesRevascularization in patients with severely reduced left ventricular function and coronary artery disease (CAD) is associated with a high perioperative risk. The in-hospital stroke rate was similar (LVAD 7 [5.4%] vs. CABG 8 [6.2%], p = 0.9). In-hospital survival, 1-year survival, and 3-year survival were 90.5%